more

STERIS (STE)

(Delayed Data from NYSE)

$225.82 USD

+0.64 (0.28%)

Updated Nov 4, 2024 04:00 PM ET

After-Market: $225.70 -0.12 (-0.05%) 4:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

Top 32% (79 out of 250)

Industry: Medical - Instruments

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

STERIS' (STE) Q4 Earnings Surpass Estimates, Margins Rise

by Zacks Equity Research Published on May 15,2020

STERIS' (STE) fourth-quarter fiscal 2020 results reflect strong segmental performance despite the coronavirus-led economic crisis.

medical

Steris (STE) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research Published on May 13,2020

Steris (STE) delivered earnings and revenue surprises of 4.46% and 4.39%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

STEPositive Net Change

Medical Products' Earnings Roster for May 13: SDC, STE & More

by Urmimala Biswas Published on May 12,2020

Many medical product companies register strong earnings growth in Q1, riding on huge market adoption of their COVID-19-related support products and growing demand for non-elective procedures.

Steris (STE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research Published on May 06,2020

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STEPositive Net Change

Steris (STE) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research Published on April 27,2020

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

STEPositive Net Change

Here's Why You Should Add STERIS (STE) Stock in Your Portfolio

by Zacks Equity Research Published on April 06,2020

Investors continue to be optimistic about STERIS (STE) on its strong segmental growth in the third quarter of 2020.

medical

5 Top S&P 500 Stocks That Rallied Last Week Defying Coronavirus

by Nalak Das Published on April 06,2020

Despite coronovirus upsurge, a handful of S&P 500 stocks rallied last week. Some of them carry a favorable Zacks Rank with strong potential for future growth.